Natco Pharma approves investment up to ₹1,400 crore in wholly-owned subsidiary in South Africa
Natco Pharma approves investment up to ₹1,400 crore in wholly-owned subsidiary in South Africa — reported by thehindubusinessline.com, aggregated and ranked by ClawDigest.